123STA T . 23 5PUBLIC LA W 111 – 5 —FE B.1 7, 2 0 0 9‘ ‘ (iv)Technol o g ie st h a tasa p a r to f a qu alifie d electronic health record allo w for an accounting of disclosures m ade by a covered entity (as defined for purposes of regulations promulgated under section 264 (c) of the H ealth I nsurance P ortability and A ccount - ability Act of 19 96) for purposes of treatment , payment, and health care operations (as such terms are defined for purposes of such regulations) . ‘‘(v) The use of certified electronic health records to improve the quality of health care, such as by pro- moting the coordination of health care and improving continuity of health care among health care providers, by reducing medical errors, by improving population health, by reducing health disparities, by reducing chronic disease, and by advancing research and edu- cation. ‘‘(vi) Technologies that allow individually identifi- able health information to be rendered unusable, unreadable, or indecipherable to unauthori z ed individ- uals when such information is transmitted in the nationwide health information networ k or physically transported outside of the secured, physical perimeter of a health care provider, health plan, or health care clearinghouse. ‘‘(vii) The use of electronic systems to ensure the comprehensive collection of patient demographic data, including, at a minimum, race, ethnicity, primary lan- guage, and gender information. ‘‘(viii) Technologies that address the needs of chil- dren and other vulnerable populations. ‘‘( C ) OTHERA REA SFO R C O N S ID ERATION. — In making recommendations under subparagraph (A), the HIT Policy Committee may consider the following additional areas
‘‘(i) The appropriate uses of a nationwide health information infrastructure, including for purposes of— ‘‘(I) the collection of quality data and public reporting
‘‘(II) biosurveillance and public health; ‘‘(III) medical and clinical research; and ‘‘(I V ) drug safety. ‘‘(ii) S elf-service technologies that facilitate the use and e x change of patient information and reduce wait times. ‘‘(iii) Telemedicine technologies, in order to reduce travel requirements for patients in remote areas. ‘‘(iv) Technologies that facilitate home health care and the monitoring of patients recuperating at home. ‘‘(v) Technologies that help reduce medical errors. ‘‘(vi) Technologies that facilitate the continuity of care among health settings. ‘‘(vii) Technologies that meet the needs of diverse populations. ‘‘(viii) M ethods to facilitate secure access by an individual to such individual ’ s protected health information. ‘‘(ix) Methods, guidelines, and safeguards to facili- tate secure access to patient information by a family
